These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23021156)

  • 21. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
    Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
    BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early prostate cancer--which treatment do men prefer and why?
    Anandadas CN; Clarke NW; Davidson SE; O'Reilly PH; Logue JP; Gilmore L; Swindell R; Brough RJ; Wemyss-Holden GD; Lau MW; Javle PM; Ramani VA; Wylie JP; Collins GN; Brown S; Cowan RA;
    BJU Int; 2011 Jun; 107(11):1762-8. PubMed ID: 21083643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.
    Daum LM; Reamer EN; Ruterbusch JJ; Liu J; Holmes-Rovner M; Xu J
    J Am Board Fam Med; 2017; 30(3):288-297. PubMed ID: 28484061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative.
    Paudel R; Ferrante S; Qi J; Dunn RL; Berry DL; Semerjian A; Brede CM; George AK; Lane BR; Ginsburg KB; Montie JE; Lane GI;
    Urology; 2021 Sep; 155():55-61. PubMed ID: 33933504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary treatment considerations among men with newly diagnosed prostate cancer.
    Zeliadt SB; Moinpour CM; Blough DK; Penson DF; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
    Am J Manag Care; 2010 May; 16(5):e121-30. PubMed ID: 20455638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
    Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance.
    Formica MK; Wason S; Seigne JD; Stewart TM
    Patient Educ Couns; 2017 May; 100(5):812-817. PubMed ID: 27923674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Men's perspectives on selecting their prostate cancer treatment.
    Xu J; Dailey RK; Eggly S; Neale AV; Schwartz KL
    J Natl Med Assoc; 2011 Jun; 103(6):468-78. PubMed ID: 21830629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
    Shirk JD; Crespi CM; Saucedo JD; Lambrechts S; Dahan E; Kaplan R; Saigal C
    Patient; 2017 Dec; 10(6):785-798. PubMed ID: 28623628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium.
    Diefenbach MA; Marziliano A; Tagai EK; Pfister H; Lapitan E; Hall SJ; Vira M; Ibrahim S; Aibel K; Kutikov A; Horwitz EM; Miyamoto C; Reese AC; Miller SM
    J Med Internet Res; 2023 Oct; 25():e46552. PubMed ID: 37862103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
    Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
    J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of health information-seeking behavior and personal factors on preferred role in treatment decision making in men with newly diagnosed prostate cancer.
    Davison BJ; Breckon EN
    Cancer Nurs; 2012; 35(6):411-8. PubMed ID: 22067700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer.
    Gries KS; Regier DA; Ramsey SD; Patrick DL
    Value Health; 2016; 19(2):218-25. PubMed ID: 27021756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial.
    Lamers RED; Cuypers M; de Vries M; van de Poll-Franse LV; Bosch JLHR; Kil PJM
    World J Urol; 2021 Dec; 39(12):4327-4333. PubMed ID: 34272972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.
    Houédé N; Rébillard X; Bouvet S; Kabani S; Fabbro-Peray P; Trétarre B; Ménégaux F
    BMC Cancer; 2020 Aug; 20(1):757. PubMed ID: 32787797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients' perceptions of quality of life after treatment for early prostate cancer.
    Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
    J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated with Decision Aid Use in Localized Prostate Cancer.
    Lane GI; Dupati A; Qi J; Ferrante S; Dunn RL; Paudel R; Wittmann D; Wallner L; Berry DL; Ellimoottil C; Montie J; Clemens JQ
    Urol Pract; 2022 Jan; 9(1):108-115. PubMed ID: 35722246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
    Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
    J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
    Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
    J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.